MedTrace Logo

Effects of Gongs Mobilization and Proprioceptive Neuromuscular Facilitation in Patients With Adhesive Capsulitis

NCT07576127 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2026-05-08

No results posted yet for this study

Summary

The randomized controlled trail aims is to evaluate the outcome of Gongs mobilization and PNF in patients with adhesive capsulitis. The significance of this study is to compare Gong's mobilization technique with proprioceptive neuromuscular facilitation (PNF) compare their effects on pain, range of motion, and functional disability. The sample size was calculated with G-power. This study would include total 44 female participants aged 40-60 years will be recruited and randomly assigned to two groups. Group A(Gongs mobilization+ conventional therapy)and Group B(PNF+ Conventional therapy). Intervention will be provided for 4 weeks 3 session per week. Primary outcome measures are pain, ROM and functional disability via NPRS, Goniometer and U-SPADI. Outcomes will be reassessed at baseline, after 2nd week, and after 4th week.

Conditions

  • Adhesive Capsulitis

Interventions

BEHAVIORAL

Gongs Mobilization

Glenohumeral mobilization (GM) will be performed in a side-lying position with the therapist standing on the affected side. An anterior-to-posterior glide will be applied to the humeral head parallel to the joint plane while the opposite hand stabilizes the scapula from posterior to anterior. The patient will perform quick shoulder abduction movements with the elbow extended as the therapist applies Maitland's Grade III-IV oscillatory glides, maintaining slight joint distraction and following the motion through the abduction phase. Each session will include two sets of five repetitions with a five-minute rest between sets, for a total of twelve sessions

BEHAVIORAL

Proprioceptive Neuromuscular Facilitation

The therapist will use proprioceptive neuromuscular facilitation (PNF) techniques specifically employing the hold-relax method followed by the D2 pattern of flexion-extension movement. Each session will last 15 minutes, comprising 10 sets of PNF. Each set will include 5 repetitions, with a 5-second hold and a 2-second rest between repetitions. This protocol will be administered over 12 sessions.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Fatima Miraj, DPT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-01
Primary Completion
2026-05-05
Completion
2026-05-15

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07576127 on ClinicalTrials.gov